About
Phil Ball, PhD, is a biopharmaceutical executive and founding team member at Tolerance Bio, where he serves as Chief Business Officer. His background spans business development, alliance management, licensing, fundraising support, and corporate strategy across venture-backed biotech and large pharmaceutical companies. Prior to Tolerance Bio, he held senior business-development roles at Provention Bio and earlier positions at Allergan, Actavis, Watson Pharmaceuticals, and Eden Biodesign.
Areas of interest
biotechimmunologyimmune tolerancecell therapyautoimmune diseaselongevityhealthspanbusiness developmentlicensingstrategic partnershipsbiopharma M&A